Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

3361 - 3370 of 44979 results found

Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review

Date
Saturday, February 17, 2024 - 4:00 AM
Description
Antivirals with proven effectiveness against the Omicron SARS-CoV-2 variant are required for COVID-19 treatment in hospitalized patients, particularly those with severe underlying conditions. Ensitrelvir, a 3C-like protease inhibitor, received

Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein

Date
Saturday, February 17, 2024 - 4:00 AM
Description
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially damaged the global economy and human health. The spike (S) protein of coronaviruses plays a pivotal role in viral entry by binding to